MENS
Jyong Biotech Ltd. Ordinary Shares NASDAQ Listed Jun 17, 2025$2.08
Mkt Cap $157.8M
52w Low $1.43
1.0% of range
52w High $67.00
50d MA $2.23
200d MA $23.17
P/E (TTM)
-56.7x
EV/EBITDA
-422.0x
P/B
—
Debt/Equity
-0.5x
ROE
—
P/FCF
-212.1x
RSI (14)
—
ATR (14)
—
Beta
8.47
50d MA
$2.23
200d MA
$23.17
Avg Volume
254.2K
Jyong Biotech Ltd. is a Taiwan-based biotech firm focused on developing and commercializing plant-derived drugs targeting urinary system diseases. The company operates through its subsidiaries—Health Ever Bio-Tech, Genvace, and others—working on drug candidates like MCS‑2 (for BPH) currently in Phase III, PCP (for prostate cancer) in Phase II, and IC in pre-clinical stages
23F‑3, No. 95, Section 1, Xintai 5th Road · New Taipei City 221 · TW
Data updated apr 26, 2026 11:51am
· Source: massive.com